Xiang Zhai

Xiang Zhai's work experience begins in 2014 as a Postdoctoral Research Associate at Texas A&M University. They held this role until February 2017. In February 2017, Xiang Zhai joined AstraZeneca as a Senior Scientist and held this position until June 2020. From June 2020 to November 2021, they worked as an Associate Principal Scientist at AstraZeneca. Currently, Xiang Zhai is a Principal Scientist at Allorion Therapeutics starting in November 2021.

Xiang Zhai earned a Bachelor of Science degree from China Pharmaceutical University, where the field of study is unspecified, between 2005 and 2009. Subsequently, from 2009 to 2014, they pursued a Doctor of Philosophy in Enzymology at the University at Buffalo.